MIMOSA Diagnostics
About MIMOSA Diagnostics
MIMOSA Diagnostics is a healthcare AI company that has developed the MIMOSA Pro, a portable, handheld near-infrared tissue imaging device designed to provide real-time, non-invasive assessment of tissue health at the point-of-care. This innovative technology allows clinicians to visualize physiological biomarkers beneath the skin’s surface, independent of skin pigmentation, which are often not visible to the naked eye. The device aims to democratize access to critical tissue information, enabling earlier interventions and improving patient outcomes across various clinical settings. [1, 3, 5, 6, 14]
The MIMOSA Pro is particularly impactful in areas such as wound care, peripheral vascular disease, diabetic foot ulcer prevention, burn assessment, and monitoring post-operative surgical complications. Images captured by the device are uploaded to a secure, HIPAA-compliant web portal, facilitating remote monitoring of patient progress, identification of early opportunities for intervention, and collaborative care among healthcare professionals. By providing objective data for proactive skin health management, MIMOSA Diagnostics seeks to save limbs and lives, while also promoting equitable and accessible healthcare globally. [3, 4, 5, 6, 8, 9, 14]
Focus Areas
Business Intelligence
| Key Investors | Kern Venture Group, Kindling Investment Partners, Spring Impact Capital, Raspberry Investment Corporation, Archerwill Investments, XDL Group, Ontario Centre for Innovation (Life Sciences Innovation Fund), Tidal Venture Partners, Mimosa Partners, MEDTEQ |
| Partnerships | Henson Shaving (research deal), St. Michael's Hospital, Downtown East Toronto Ontario Health Team (DETOHT) Lower Limb Preservation Program, Wound Care Advantage Centers, University of New Brunswick (Healthy Seniors project) |
| Technology | Handheld, pocket-sized, multispectral skin imaging device (MIMOSA Pro), near-infrared (NIR) light, secure cloud-based web portal, AI/machine learning, tissue oximetry, temperature, wound measurement, digital biomarkers, smartphone-paired |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
MIMOSA Diagnostics stands out for physicians by offering a non-invasive, objective method for early detection of tissue compromise, which can significantly improve patient outcomes by enabling timely intervention. This can lead to reduced rates of amputations, infections, and prolonged healing times, particularly in high-risk patients with diabetic foot ulcers or peripheral vascular disease. The technology provides quantifiable data to support clinical decision-making, track treatment efficacy, and potentially reduce healthcare costs associated with advanced complications. Its focus on equitable healthcare also means it can be a valuable tool for reaching underserved populations and standardizing care.
While specific integration details are not provided, given their focus on objective data and early detection, MIMOSA Diagnostics' solutions would likely benefit from seamless integration with Electronic Health Records (EHR) systems for streamlined data capture, patient monitoring, and longitudinal tracking of tissue health. Integration with telehealth platforms could also extend their reach for remote patient assessment and follow-up.
What the Web Says
MIMOSA Diagnostics is a Canadian company that has developed a portable, handheld imaging device called MIMOSA Pro, which uses near-infrared light to assess tissue health and aid in early intervention for skin injuries, particularly for conditions like diabetic foot ulcers. The company aims to make healthcare more equitable by providing accessible diagnostic tools and developing algorithms that account for all skin tones. Employer reviews are limited but generally positive, highlighting a fast-paced startup environment with a good culture and supportive management.
Overall: PositiveStrengths
- Great company culture and people
- Fast-paced and challenging startup environment
- Product (MIMOSA Pro) offers early intervention for improved patient outcomes
- Portable and easy-to-use device for healthcare professionals
- Promotes equitable healthcare by being effective across all skin tones
- Secure, cloud-based platform for patient data and collaboration
Limitations
- Limited number of employee reviews available
- Some ambiguity due to startup nature
- Specific product reviews from independent healthcare IT reviewers, G2, Capterra, and Glassdoor are not readily available.
- Reddit discussions about 'Mimosa' or 'Mosaic Diagnostics' appear to refer to different companies or products, primarily related to cannabis or mold testing, and are not relevant to MIMOSA Diagnostics' medical imaging device.
Based on reviews from: Workopolis, Indeed.com, MIMOSA Diagnostics website, YouTube (MaRS Discovery District), Reddit
Last updated: 2026-07-18
Videos
News, demos, and interviews about MIMOSA Diagnostics.
Videos load interactively. If none appear, search YouTube for MIMOSA Diagnostics →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]